NIPT Advanced by N Health provides expanded non-invasive prenatal screening from 10 weeks of pregnancy. It analyses placental cell-free DNA circulating in maternal blood to screen for chromosomal abnormalities across chromosomes 1–22 and the sex chromosomes.
The screening includes:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Aneuploidies affecting chromosomes 1–22
- Monosomy X (Turner syndrome)
- XXX (Triple X syndrome)
- XXY (Klinefelter syndrome)
- XYY (Jacobs syndrome)
- Fetal sex reporting
NIPT is a screening test and does not provide a definitive diagnosis. A high-probability result should be discussed with a healthcare professional and may require confirmation through chorionic villus sampling or amniocentesis. A low-probability result does not exclude every genetic condition or birth defect and does not replace recommended prenatal ultrasound examinations or routine antenatal care.
